Package 68001-669-15

Brand: aprepitant

Generic: aprepitant
NDC Package

Package Facts

Identity

Package NDC 68001-669-15
Digits Only 6800166915
Product NDC 68001-669
Product ID 68001-669_4496621d-8b64-8aae-e063-6294a90a95e9
Description

1 KIT in 1 DOSE PACK (68001-669-15) * 2 CAPSULE in 1 BLISTER PACK * 1 CAPSULE in 1 BLISTER PACK

Marketing

Marketing Status
Marketed Since 2025-12-01
Brand aprepitant
Generic aprepitant
Sample Package No

Linked Drug Pages (1)

Aprepitant ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"spl_id": "4496621d-8b64-8aae-e063-6294a90a95e9", "openfda": {"nui": ["N0000010262", "N0000175786", "N0000182141", "N0000185507", "N0000185506"], "upc": ["0368001669153"], "unii": ["1NF15YR6UY"], "rxcui": ["403810", "403811", "644088", "754508"], "spl_set_id": ["a78aaa00-a46b-4f9e-a415-2fca9e9a4fb4"], "pharm_class_epc": ["Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Neurokinin 1 Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 KIT in 1 DOSE PACK (68001-669-15)  *  2 CAPSULE in 1 BLISTER PACK *  1 CAPSULE in 1 BLISTER PACK", "package_ndc": "68001-669-15", "marketing_start_date": "20251201"}], "brand_name": "Aprepitant", "product_id": "68001-669_4496621d-8b64-8aae-e063-6294a90a95e9", "dosage_form": "KIT", "product_ndc": "68001-669", "generic_name": "Aprepitant", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Aprepitant", "application_number": "ANDA207777", "marketing_category": "ANDA", "marketing_start_date": "20251201", "listing_expiration_date": "20261231"}